Casodex is a brand name of bicalutamide, approved by the FDA in the following formulation(s):
CASODEX (bicalutamide - tablet; oral)
Manufacturer: ASTRAZENECA
Approval date: October 4, 1995
Strength(s): 50MG [RLD][AB]
Has a generic version of Casodex been approved?
A generic version of Casodex has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Casodex and have been approved by the FDA:
bicalutamide tablet; oral
Manufacturer: ACCORD HLTHCARE INC
Approval date: July 6, 2009
Strength(s): 50MG [AB]
Manufacturer: ACTAVIS TOTOWA
Approval date: August 28, 2009
Strength(s): 50MG [AB]
Manufacturer: FRESENIUS KABI ONCOL
Approval date: May 13, 2010
Strength(s): 50MG [AB]
Manufacturer: KUDCO IRELAND
Approval date: July 6, 2009
Strength(s): 50MG [AB]
Manufacturer: MYLAN
Approval date: July 6, 2009
Strength(s): 50MG [AB]
Manufacturer: ROXANE
Approval date: March 24, 2011
Strength(s): 50MG [AB]
Manufacturer: SANDOZ
Approval date: July 6, 2009
Strength(s): 50MG [AB]
Manufacturer: SUN PHARMA GLOBAL
Approval date: July 6, 2009
Strength(s): 50MG [AB]
Manufacturer: SYNTHON PHARMS
Approval date: July 6, 2009
Strength(s): 50MG [AB]
Manufacturer: TEVA
Approval date: July 6, 2009
Strength(s): 50MG [AB]
Manufacturer: ZYDUS PHARMS USA INC
Approval date: July 6, 2009
Strength(s): 50MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Casodex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Casodex.
Related Exclusivities
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
See also...
- Casodex Consumer Information (Drugs.com)
- Casodex Consumer Information (Wolters Kluwer)
- Casodex Consumer Information (Cerner Multum)
- Casodex Advanced Consumer Information (Micromedex)
- Casodex AHFS DI Monographs (ASHP)
- Bicalutamide Consumer Information (Wolters Kluwer)
- Bicalutamide Consumer Information (Cerner Multum)
- Bicalutamide Advanced Consumer Information (Micromedex)
- Bicalutamide AHFS DI Monographs (ASHP)